Latest Breaking News On - Velocity clinical - Page 4 : comparemela.com
Healthcare Transactions Q2 2021 | Bass, Berry & Sims PLC
jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.
Non-COVID-19 clinical trials are mounting a comeback as the pandemic s shadow lifts
sandiegouniontribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegouniontribune.com Daily Mail and Mail on Sunday newspapers.
Velocity Clinical Research acquired by GHO signalling evolution of clinical trial site industry
News provided by
Share this article
Share this article
DURHAM, N.C., April 8, 2021 /PRNewswire/ Leading integrated clinical trial site organisation, Velocity Clinical Research ( Velocity ), today announces it has entered into an agreement with Global Healthcare Opportunities, or GHO Capital ( GHO ), the European specialist investor in healthcare, to be acquired from NaviMed Capital ( NaviMed ) and other investors, signalling how the business of running clinical trial sites is changing.
Headquartered in Durham, North Carolina, Velocity operates 16 fully-owned sites across 11 US states. The company serves biopharmaceutical and contract research organisation (CRO) clients in primarily conducting phase II and phase III clinical trials in support of their global drug development programs. In just three years, Velocity has worked with over 200 biopharmaceutical clients, including all of
Velocity Clinical Research acquired by GHO signalling evolution of clinical trial site industry
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
DURHAM – Velocity Clinical Research, which is headquartered in Durham, has acquired two additional firms in expanding its national reach to 16 total sites.
According to the company, the purpose of the acquisition of Denver-based Downtown Women’s Health Care and Riverside Clinical Research in Edgewood, Florida is to increase volunteer recruitment from communities traditionally underrepresented in clinical research as well as an expansion into renal and hepatic research.
Financial terms were not disclosed.
“We’re committed to recruiting a diverse set of volunteers to the trials we conduct,” said Dr G. Paul Evans, president and CEO of Velocity Clinical Research. “Putting sites near minority populations is one way to encourage more people from these communities to take part in clinical research.”